Serum cytokines associated with severity and complications of kala-azar.
about
Systematic review of biomarkers to monitor therapeutic response in leishmaniasisRisk factors for adverse prognosis and death in American visceral leishmaniasis: a meta-analysisThe Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14.Hyponatremia and risk factors for death in human visceral leishmaniasis: new insights from a cross-sectional study in Brazil.Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease.Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia.Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance.Preclinical diagnosis of American visceral leishmaniasis during early onset of human Leishmania (L.) infantum chagasi-infection.Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice.Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patientsImmunomodulatory and Antileishmanial Activity of Phenylpropanoid Dimers Isolated from Nectandra leucantha.The Nlrp3 inflammasome, IL-1β, and neutrophil recruitment are required for susceptibility to a nonhealing strain of Leishmania major in C57BL/6 mice.Visceral Leishmaniasis Patients Display Altered Composition and Maturity of Neutrophils as well as Impaired Neutrophil Effector Functions.Bone marrow parasite burden among patients with New World kala-azar is associated with disease severityLeishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis.Prognostic factors for death from visceral leishmaniasis in patients treated with liposomal amphotericin B in an endemic state in Brazil.Causes and consequences of higher Leishmania infantum burden in patients with kala-azar: a study of 625 patients.Predicting death from kala-azar: construction, development, and validation of a score set and accompanying software.Serum Cytokine Responses over the Entire Clinical-Immunological Spectrum of Human Leishmania (L.) infantum chagasi Infection.Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc N-glycosylation.Biomarkers for Zoonotic Visceral Leishmaniasis in Latin America
P2860
Q26866450-EE0C0759-9236-4CD7-98BC-75458615BF55Q27024638-6A3AD2FB-8190-4D96-A94C-9E60383376FCQ33429539-CF19A71B-2E2B-4617-B43D-9C2948251FDCQ33439578-99CED532-0F78-46C8-90E8-CE48BACE88F9Q33749424-868FB7B7-9E6C-47CD-9218-C2BF00FA0118Q33764787-8FA90F20-DB11-4C96-A5E0-842988B8D458Q33849243-6C73A934-2863-492C-9B2F-D42AD8B2F094Q35383603-D3E6DACF-556B-4D93-AC68-CD8D58F5C71FQ36237748-E28E89D3-CA8D-48EB-B086-BF980DFCB7CBQ36243677-FA1BED84-68D1-476F-A7F0-40E44EA886CAQ36514153-615AEDF7-0703-4EF7-9868-F08BCD91D4F8Q36788745-A71C74D2-452C-4AA8-B1A0-4D8D593EA024Q37447272-B4AD7F37-583C-498F-A9FA-8BBBCAE9B6F7Q37680697-4B3B7AA5-ABF4-438B-85AE-57117116630FQ37681902-1D38487A-0CEF-4899-AE3F-1F0B2B67D195Q38695939-755AF353-758A-4801-ABD1-677EA36A3B6EQ38852454-BC92C59A-1B15-4182-B5CD-4152AF2E92A2Q39078116-65A5FFF1-BF02-488E-A4B8-BFCBBA407BEEQ39381958-D88B198E-B097-446E-97FA-992BD08FF3C0Q41622831-0F3CE52F-C8E4-4EED-BF74-EE48972D1C09Q57952511-734A747C-1324-4452-A852-69D248663C4B
P2860
Serum cytokines associated with severity and complications of kala-azar.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum cytokines associated with severity and complications of kala-azar.
@en
Serum cytokines associated with severity and complications of kala-azar.
@nl
type
label
Serum cytokines associated with severity and complications of kala-azar.
@en
Serum cytokines associated with severity and complications of kala-azar.
@nl
prefLabel
Serum cytokines associated with severity and complications of kala-azar.
@en
Serum cytokines associated with severity and complications of kala-azar.
@nl
P2093
P2860
P50
P1476
Serum cytokines associated with severity and complications of kala-azar
@en
P2093
Adelino S Lima-Neto
Aldina P Barral
Carlos Henrique N Costa
Dorcas L Costa
Rayssa M A Carvalho
P2860
P356
10.1179/2047773213Y.0000000078
P577
2013-03-01T00:00:00Z